Prof Dr Jan-Willem Alffenaar

Professor of Clinical Pharmacy Faculty of Medicine and Health, School of Pharmacy, University of Sydney, Sydney, Australia

Prof Jan-Willem began his career as a pharmacist at the University Medical Center Groningen, Netherlands. As a pharmacist and clinical pharmacologist, he is now the Chair of Clinical Pharmacy at the University of Sydney and Westmead Hospital (WSLHD). His research specialises in PK/PD of antimicrobials, focusing on personalised dosing for tuberculosis and fungal infections, using dried blood spot and saliva sampling. He also leads AMR and novel therapies at the Sydney Infectious Disease Institute.

Prof Dr Deborah JE Marriott

Clinical Director, Antimicrobial TDM Group, St. Vincent’s Hospital, Sydney, Australia

Prof Deborah is a senior specialist in Clinical Microbiology and Infectious Diseases at St. Vincent’s Hospital, Sydney, with conjoint and adjunct professorships at UNSW and UTS. Since 1995, she has led numerous clinical trials and research projects. With 40 years of expertise in teaching, research, publications, and grant acquisition, she specialises in microbiology, pathology, clinical treatment, and TDM in infectious diseases.

Dr Mo Yin

Consultant, Division of Infectious Diseases, Department of Medicine, National University Hospital, Singapore

Dr Mo Yin is the Deputy Director of the ADVANCE-ID clinical trial network and an Infectious Diseases physician at the National University Hospital in Singapore. She leads the REGARD-VAP and ACORN-HAI studies, focusing on antibiotic resistance. With extensive experience in multinational clinical trials, Dr Mo Yin aims to improve patient outcomes and influence global healthcare policies. She obtained her MBBS from the National University of Singapore and DPhil from the University of Oxford.

Prof Dr Graham Jones

Specialist in Chemical Pathology SydPath, St. Vincent’s Hospital, Sydney, Australia

Prof Graham Jones is a Chemical Pathologist at SydPath, St Vincent's Hospital, Sydney, and a conjoint Professor at the University of New South Wales. He is involved nationally and internationally in areas such as traceability of lab results, external quality assurance, kidney disease testing, diabetes diagnosis, therapeutic drug monitoring, common reference intervals, and lab reporting harmonisation. He is also active in teaching and research, with over 100 peer-reviewed papers.

Mr Muhammad Taimoor Chaudhary

Senior Pharmacist (Forensic Toxicology), The Medical City for Military & Security Services, Masqaţ, Oman

Mr Taimoor is a forensic expert and Sr. Pharmacist (Forensic Toxicology) at the Ministry of Defence, Oman. With over a decade of experience, he specialises in forensic toxicology and drug chemistry. As a member of international forums such as RAPS, Mr Taimoor is skilled in analysing biological specimens to determine cause of death, method development, validation, and ISO standards implementation. He contributed to Oman's national antimicrobial guidelines by improving the TDM chapter and overseeing the TDM service.

Dr George Tharayil John

Senior Consultant, Transplant Physician Department of Renal Medicine, Royal Brisbane & Women’s Hospital, Brisbane, Australia

Dr George T John is a Renal Senior Consultant at Royal Brisbane & Women’s Hospital, Australia, and an Adjunct Professor of Nephrology at Christian Medical College, Vellore, India. His research focuses on renal transplantation and immunosuppressants. Dr George has co-authored a vast number of publications and books on kidney transplantation and is affiliated with the University of Queensland and various International Nephrology and Transplantation societies.

Dr Cindy Lau

Antimicrobial Stewardship Pharmacist, St Vincent's Hospital, Sydney, Australia

Dr Cindy is the Antimicrobial Stewardship Pharmacist at St Vincent’s Hospital in Sydney, Australia. She completed her PhD in antimicrobial therapeutic drug monitoring and toxicity in University of Sydney. Her professional interests include the clinical implementation of antimicrobial therapeutic drug monitoring and optimising treatment for infections in immunocompromised patients.

Dr Jana Stojanova

Department of Clinical Pharmacology, St. Vincent’s Hospital, Sydney, Australia

Dr Jana Stojanova is a clinical pharmacist and research scientist with extensive international experience across Australia, France, and Chile. Currently serving as Senior Scientist at St Vincent's Hospital Sydney and Senior Lecturer at UNSW, she specialises in optimising medicine use through clinical pharmacology, therapeutic drug monitoring, and pharmacogenomics. Dr Stojanova is co-chair of the upcoming IATDMCT Singapore 2025 congress.

Prof Sumith K Mathew

Believers Church Medical College Hospital, Thiruvalla, Kerala, India

Prof Sumith K. Mathew is a clinical pharmacologist at Believers Church Medical College in Thiruvalla, Kerala. With over 10 years of experience in TDM, he has developed expertise in Analytical Chemistry, Pharmacometrics, Model-informed Precision Dosing, and alternative sampling techniques. He currently serves as the Vice Chair of the Regional Asia Pacific Section of IATDMCT. Prof Sumith has contributed extensively to research and publications on antimicrobial dosing regimens, as well as analytical methods for antineoplastics and immunosuppressants.

Dr Suzana Mustafa

Clinical Pharmacist, Department of Pharmacy, Hospital Raja Perempuan Zainab II, Kelantan, Malaysia

Dr Suzana Mustafa is a clinical pharmacist at HRPZ II, Malaysia, and an IATDMCT member since 2015. She helps advancing pharmacokinetics and precision medicine in Malaysia, serving as Chairperson of the Clinical Pharmacy Working Committee (CPS), Head of the Task Force on Precision Medicine and Genomic ADR, and MyACPP preceptor. Her research and publication contributions were recognised with the Research Mentors Award at the 12th National Pharmacy R&D Conference 2024.

Dr Nathalie Grace Sy CHUA

Division of Pharmacy, Singapore General Hospital, Singapore

Dr Nathalie Chua is a Specialist Pharmacist in Infectious Diseases at Singapore General Hospital, co-leading antimicrobial TDM with novel therapeutic strategies for difficult-to-treat infections. Her research focuses on PK/PD, TDM, and antimicrobial resistance. She leads the beta-lactam TDM study in Singapore General Hospital, with publications in renowned journals. Dr Chua also leads antiretroviral stewardship service, teaches infectious diseases for pharmacy residents and the PharmD programme. She contributes to national guidelines for surgical antibiotic prophylaxis and HIV management in Singapore.

Assoc Prof Dr Dinh Hoa VU

National Drug Information and Adverse Drug Reaction Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam

Assoc Prof Dr Vu Dinh Hoa is Deputy Director of the Vietnam National Drug Information and Adverse Drug Event Monitoring Center, a lecturer at Hanoi University of Pharmacy, and an adjunct researcher at Vietnam National Children’s Hospital. His research focuses on optimising antimicrobial use based on PK/PD, dried blood spots and TDM for antituberculosis drugs. He supervises TDM teams for vancomycin and amikacin and leads research on Model Informed Precision Dosing (SmartDoseAI®) for vancomycin. He collaborates with intensivists and pediatricians to guide antimicrobial treatment for critically ill patients, neonates, and those on Renal Replacement Therapy.

Prof Dr Yuetian YU

Department of Critical Care Medicine, Renji Hospital School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Prof Yu Yuetian is a Chief Physician at Renji Hospital and has nearly twenty years of experience in critical care. He leads the Key Laboratory of Multiple Organ Failure in Hangzhou and the Key Laboratory of Intelligent Pharmacy and Individualised Therapy in Huzhou. His research interests include the treatment of sepsis in critically ill patients, with a particular focus on TDM, invasive fungal infections, mechanical ventilation, bronchoscopy, and data mining.

Mr Bin LIN

Pharmacy Department, Changxing People’s Hospital, Zhejiang Province, China

Mr Lin Bin, Director of Clinical Pharmacy at Changxing People's Hospital, is a critical care pharmacist specialising in therapeutic drug monitoring. He leads clinical practice and research at the Key Laboratory of Intelligent Pharmacy and Individualised Therapy of Huzhou. His work focuses on individualised antibiotic therapy in critically ill patients. As a committee member of IATDMCT’s Asia-Pacific Section (RAPS), he promotes international collaboration in TDM between China and the Asia-Pacific countries.

Assoc Prof Dr Ryota TANAKA

Department of Clinical Pharmacy, Oita University Hospital, Oita, Japan

Assoc Prof Dr Ryota Tanaka is an Associate Professor & Deputy Director at the Department of Clinical Pharmacy, Oita University Hospital, Japan. He earned his Ph.D. from Kumamoto University in Japan in 2014. He contributes to antimicrobial stewardship by providing novel evidence for antimicrobial TDM. His research focuses on PK/PD modelling and simulation to optimise dosing in special populations. He received the Best TDM Poster Presentation Award at the 2024 IATDMCT Banff Congress.

Prof Dr Rovina Ruslami

Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia

Prof Dr Rovina Ruslami is an internal medicine specialist and clinical pharmacologist by training at the Faculty of Medicine, Universitas Padjadjaran, Bandung, and Hasan Sadikin Teaching Hospital. Her research focuses on tuberculosis pharmacotherapy. She is dedicated to establishing TDM services in Indonesia, recognising TDM as essential for improving better patient care.

Assoc Prof Dr Shu-Wen LIN

School of Pharmacy, National Taiwan University, Taipei, Taiwan

Assoc Prof Dr Shu-Wen "Wendy" Lin, PharmD, MSc, is Director of Pharmacy at NTU Cancer Center, Taipei. Her expertise includes TDM and precision medicine for antimicrobials and cancer therapy. She has received multiple honours, including Teaching Excellence Awards and the Ching-Kang Foundation Junior Faculty Award. Dr Lin holds affiliations with IATDMCT, ACCP, and Taiwan professional societies. She has co-authored international articles and contributed to TDM programmes for new antibacterial and antifungal agents in Taiwan.

Assist Prof Dr Denpong Patanasethanont

Division of of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand

Assist Prof Dr Denpong from Khon Kaen University, Thailand, specialises in TDM, Clinical Pharmacokinetics, Pharmacotherapy, and Clinical Pharmacology. His research focuses on Vancomycin TDM in end-stage renal disease, high-dose Methotrexate TDM for osteosarcoma, Levetiracetam analytical methods, and augmented renal clearance. His research and publications highlight his dedication to advancing TDM and optimising pharmacotherapy for various patient populations.

Mr Mohammed Issa

Departments of Infectious Diseases and Pharmacy, Waikato Hospital, Te Whatu Ora Health New Zealand Waikato, Hamilton, New Zealand

Mr Mohammed Issa is a Clinical Pharmacist Consultant specialising in infectious diseases and antimicrobial stewardship at the Australian and New Zealand College of Advanced Pharmacy (ANZCAP).His multifaceted practice spans educational and clinical roles, with a focus on tuberculosis management. His current clinical interests include the application of anti-infective PK/PD in high-risk populations and the evolving treatment landscape of mycobacterial infections.

Prof Dr Blessed Winston Arul Dhas

Department of Pharmacology and Clinical Pharmacology, Christian Medical College and Hospital, Vellore, India

Dr Blessed Winston Arul Dhas is a clinical pharmacologist and pharmacometrician with expertise in population pharmacokinetic and PKPD modelling of methadone, oxycodone, buprenorphine, and antimicrobials, especially in paediatric, surgical pain management, and critical care. He is passionate in implementing model-informed precision dosing in clinical practice. His contributions in teaching, research, and publications have earned him the Dr Paul Stephen Memorial Award and the SENATUS Award.

Prof Dr Stephanie Reuter Lange

UniSA Clinical and Health Sciences, University of South Australia, Adelaide, Australia

Prof Stephanie Reuter Lange is a Professor in Clinical Pharmacology. Her research bridges industry and clinical practice, and broadly focuses on using pharmacological principles to optimise medicine use. She collaborates with pharmaceutical companies, regulatory agencies, and clinicians to develop new drug entities and improve existing therapies for better patient care. Her work focuses on translating foundational science into clinical practice, serving as a conduit between science, policy, and the clinic.

Dr Jefman Efendi Marzuki HY

Department of Pharmacology, Medical Faculty, Universitas Surabaya, Surabaya, Indonesia

Dr Jefman is a medical doctor and clinical pharmacology specialist at Premier Hospital and Universitas Surabaya Teaching Hospital in Surabaya, where he also works as a lecturer. He currently serves as the Chairperson of the Indonesian Association of Clinical Pharmacology Specialists (PERDAFKI). Additionally, he is a committee member of the IATDMCT Asia-Pacific Regional Section. He is passionate about establishing TDM services in Indonesia.

Mr Choki DORJI

Pharmacovigilance Centre, Department of Pharmacy, Jigme Dorji Wangchuk National Referral Hospital, Thimphu, Bhutan

Mr Choki Dorji is the only clinical pharmacist to lead TDM and Pharmacovigilance services in Bhutan. He previously worked at Jigme Dorji Wangchuck National Referral Hospital and holds an MSc in Clinical Pharmacy from Mahidol University. Currently pursuing a PhD in pharmacogenomics, his dedication and significant contributions to Bhutan’s Ministry of Health have earned him the prestigious Druk Thuksey Medal Pins Award.

Dr Kazutaka ODA

Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan

Dr Kazutaka Oda, a pharmacist at Kumamoto University Hospital, specialises in antimicrobial TDM with a focus on Vancomycin and Meropenem for CRRT using model-informed precision dosing. He also contributes to the Japanese antimicrobial TDM guidelines. He developed a web application for AUC-guided Vancomycin dosing using Bayesian forecasting and the LM1010 TDM device for clinical use in Japan.

Assoc Prof Dr Sabariah Noor Harun

(Pharmacometrics & Clinical Pharmacy) Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

Dr Sabariah Noor is a pharmacometrician specialises in population PK/PD, disease progression modelling, time-to-event analysis, and simulation approaches in non-communicable and infectious diseases. She founded the S&S Pharmacometrics Research Cluster @ USM, aiming to integrate pharmacometrics as a key component of precision medicine into clinical practice in Malaysia. Dr Sabariah is also actively involved in professional organisations and editorial boards, and receiving multiple awards for her contributions to pharmacy education innovation.

Ms YEW Jie Min

Department of Pharmacy, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia

Ms Yew Jie Min is a pharmacist with over a decade of experience in hospital pharmacy services. She currently serves in the Clinical Pharmacokinetics Unit of the Pharmacy Department at Hospital Kuala Lumpur. Specialising in Therapeutic Drug Monitoring (TDM), she focuses on optimising medication dosing, monitoring drug levels, and ensuring safe, effective drug therapy to enhance patient outcomes.

Dr LOW Lee Lee

Infectious Disease Physician, Department of Medicine, Hospital Sultanah Bahiyah, Alor Setar, Kedah, Malaysia

Dr Low Lee Lee is Head of the Medical Department at Hospital Sultanah Bahiyah, Kedah, Malaysia. She also leads the Infectious Disease Unit in Kedah State and coordinates the State Infection Control and AMS committees. Dr Low is affiliated with Asia Fungal Working Group (AFWG), Malaysian Society of HIV Medicine (MAHSM), Malaysian Society of Infectious Disease and Chemotherapy (MSIDC), and Malaysian Society of Infection Control and Infectious Diseases (MyICID). She has contributed to multiple national guidelines, research and publications on antimicrobial and antiretroviral treatment.

Dr Mohd Hafiz Abdul-Aziz

The University of Queensland Centre for Clinical Research (UQCCR), The University of Queensland, Brisbane, Queensland, Australia

Dr Mohd Hafiz is an Early Career Research Fellow and Clinical Research Pharmacist at UQCCR, Australia. He currently leads the Clinical Dosing Studies and Knowledge Translation Workstream within the Antimicrobial Optimisation Group and the CRE RESPOND. His research focuses on developing innovative methods to optimise antimicrobial dosing in the ICU. Over the past five years, he has worked closely with Malaysian investigators and academic institutions on eight multi-national antimicrobial pharmacokinetic studies, including ASAP ECMO, BLING 3, BLING 3 PK/PD, and PNEUDOS.